PIK3CA and neoplasm: Here, we investigated a new treatment approach for CMT thusly: First, we confirmed the incidence of PIK3CA mutations in CMT cases, and the anticancer effect of a PIK3CA inhibitor was investigated by establishing novel canine cell lines from tumor tissues based on the presence of the mutation.